ACCESS Newswire
14 Aug 2022, 23:55 GMT+10
NEW YORK, NY / ACCESSWIRE / August 14, 2022 / Pomerantz LLP is investigating claims on behalf of investors of Intellia Therapeutics, Inc. ('Intellia' or the 'Company') (NASDAQ: NTLA). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
The investigation concerns whether Intellia and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On August 4, 2022, Intellia issued a press release 'report[ing] operational highlights and financial results for the second quarter ended June 30, 2022.' Among other items, Intellia reported a net loss of $100.7 million, or $1.33 per diluted share, slightly worse than the consensus estimate for net loss of $1.31 per diluted share. Intellia also disclosed plans to focus exclusively on developing ex vivo (out of the body) allogeneic (commonly referred to as off-the-shelf) cell therapies. In connection with this shift in focus, Intellia advised that the Company was discontinuing a clinical study evaluating the experimental cell therapy NTLA-5001.
On this news, Intellia's stock price fell $6.27 per share, or 8.74%, to close at $65.43 per share on August 4, 2022.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com
SOURCE: Pomerantz LLP
Get a daily dose of Chicago Chronicle news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Chicago Chronicle.
More InformationNEW YORK CITY, New York: Bitcoin surged to a new all-time high this week, buoyed by growing institutional interest and a wave of pro-crypto...
SHENZHEN, China: As global chip competition intensifies, Huawei Technologies is exploring new markets in the Middle East and Southeast...
LONDON/NEW YORK CITY: American grocery bills may be headed higher as coffee and orange juice prices face upward pressure from new tariffs...
BATTLE CREEK, Michigan: In a major consolidation of iconic food brands, WK Kellogg has agreed to be acquired by the owner of Ferrero...
WASHINGTON, D.C.: Filmmaker Peter Jackson's lifelong fascination with the extinct giant New Zealand flightless bird called the moa...
NEW DELHI, India: India has submitted a revised proposal to the World Trade Organization (WTO) in Geneva to implement retaliatory tariffs...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
(Photo credit: Darren Yamashita-Imagn Images) The American League and National League announced their lineups for Tuesday's All-Star...
(Photo credit: James Guillory-Imagn Images) Longtime Pittsburgh Penguins coach Mike Sullivan will make his debut behind the New York...
(Photo credit: Brian Fluharty-Imagn Images) Ceddanne Rafaela hit a two-run home run to help the Boston Red Sox stretch their winning...
(Photo credit: Stan Szeto-Imagn Images) For the third time in five races, Shane van Gisbergen leveled the field at a NASCAR Cup Series...
(Photo credit: David Banks-Imagn Images) Steven Kwan hit a go-ahead sacrifice fly in the 10th inning as the Cleveland Guardians rallied...